Search results for "Rhythm"

showing 10 items of 822 documents

Information domain approach to the investigation of cardio-vascular, cardio-pulmonary, and vasculo-pulmonary causal couplings

2011

The physiological mechanisms related to cardio-vascular (CV), cardio-pulmonary (CP), and vasculo-pulmonary (VP) regulation may be probed through multivariate time series analysis tools. This study applied an information domain approach for the evaluation of non-linear causality to the beat-to-beat variability series of heart period (t), systolic arterial pressure (s), and respiration (r) measured during tilt testing and paced breathing (PB) protocols. The approach quantifies the causal coupling from the series i to the series j (C(ij)) as the amount of information flowing from i to j. A measure of directionality is also obtained as the difference between two reciprocal causal couplings (D(i…

medicine.medical_specialtySupine positioncausalityPhysiologySpeech recognitionBaroreflexlcsh:Physiologypaced breathingconditional entropyhead-up tiltInternal medicinePhysiology (medical)medicineHeart rate variabilitybaroreflexarterial pressure variabilityrespiratory sinus arrhythmiaVagal toneRespiratory systemOriginal Researchlcsh:QP1-981business.industryheart rate variabilityCardiorespiratory fitnessBlood pressureSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaCardiologyBreathingArterial pressure variability; Baroreflex; Causality; Conditional entropy; Head-up tilt; Heart rate variability; Paced breathing; Respiratory sinus arrhythmia; Physiology; Physiology (medical)business
researchProduct

Arrhythmieprofil und Herzfrequenz bei Hyperthyreose

2008

Arrhythmia profiles and heart rates, obtained by 24-hour ECG monitoring, were analysed in 48 patients with hyperthyroidism before (T3 level: 331 +/- 108 ng/100 ml, heart rate: 95 +/- 13/min), during (T3 level: 202 +/- 98 ng/100 ml, heart rate: 85 +/- 11/min) and after (T3 level: 149 +/- 41 ng/100 ml, heart rate: 79 +/- 9/min) antithyroid treatment. 50 persons in whom organic heart disease has been excluded by invasive and noninvasive tests served as controls. Only 6% of patients had repetitive ventricular arrhythmias (Lown group IV) before treatment (controls: 4%; P greater than 0.05). Supraventricular extrasystoles were common both before and after treatment (P less than 0.001), especially…

medicine.medical_specialtySupraventricular arrhythmiaOrganic heart diseasebusiness.industryIncidence (epidemiology)General MedicineEcg monitoringInternal medicineHeart ratecardiovascular systemmedicineCardiologycardiovascular diseasesbusinessAfter treatmentDMW - Deutsche Medizinische Wochenschrift
researchProduct

Intracardiac Cardioversion for Ablation of the Atrioventricular Conduction System in Patients with Drug Resistant Atrial Flutter

1983

The technique of intracardiac cardioversion for the ablation of the atrioventricular conduction system was used in three male patients (65, 53 and 57 years of age) with atrial flutter unresponsive to medical management. In the first patient a DC current of 80 J was applied while the other patients required 300 and 400 J respectively. In the first patient a transient third degree AVblock was induced enabling the ventricular rate to be easily controlled with drugs. This patient died 5 months later of resistant congestive heart failure. Autopsy revealed no gross evidence of myocardial damage in the tricuspid valve area or in the interventricular septum. In the other two patients a permanent th…

medicine.medical_specialtySupraventricular arrhythmiabusiness.industrymedicine.medical_treatmentAutopsyAblationCardioversionmedicine.diseaseIntracardiac injectionmedicine.anatomical_structureInternal medicineHeart failurecardiovascular systemCardiologyMedicinecardiovascular diseasesInterventricular septumbusinessAtrial flutter
researchProduct

Sympathetic Overactivity and 24-Hour Blood Pressure Pattern in Hypertensives with Chronic Renal Failure

1995

In order to assess the activity of the sympathetic system and to evaluate the 24-h blood pressure pattern in hypertensives with chronic renal failure (CRF), 12 CRF patients and 16 essential hypertensives (EHs) were studied. In all subjects, plasma samples for catecholamines and renin activity were obtained both in the basal condition and after standing, and 24-h blood pressure monitoring (ABPM) was performed. The 24-h mean blood pressure results were quite similar between CRFs and EHs. In 50% of the CRFs, ABPM showed a nighttime decrease in diastolic BP (DBP) greater than 10%, while in the remaining 50% the ABPM indicated a nondipper blood pressure pattern. Of the 16 EHs, 4 had a nighttime …

medicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemEpinephrineDiastoleBlood PressureCritical Care and Intensive Care MedicinePlasma renin activityNorepinephrineBasal (phylogenetics)CatecholaminesInternal medicineBlood plasmaHumansMedicinebusiness.industryGeneral MedicineBlood Pressure Monitoring AmbulatoryCircadian RhythmMean blood pressureBlood pressuremedicine.anatomical_structureEndocrinologyNephrologyHypertensionCatecholamineKidney Failure Chronicbusinessmedicine.drugRenal Failure
researchProduct

Multiscale Information Decomposition Dissects Control Mechanisms of Heart Rate Variability at Rest and During Physiological Stress.

2019

Heart rate variability (HRV

medicine.medical_specialtyTechnology and Engineering0206 medical engineeringRR intervalRESPIRATORY SINUS ARRHYTHMIAPERIODGeneral Physics and Astronomysynergylcsh:Astrophysics02 engineering and technologyBiologyBaroreflexArticle03 medical and health sciences0302 clinical medicinestomatognathic systemInternal medicinelcsh:QB460-466RespirationMedicine and Health Sciencesmedicineotorhinolaryngologic diseasesHeart rate variabilitycardiovascular diseasesVagal tonelcsh:SciencePhysiological stressinformation theoryBAROREFLEXredundancyheart rate variabilityvirus diseasesmultiscale analysisEntropy cardiovascular variability redundancy autonomic nervous system020601 biomedical engineeringlcsh:QC1-999ARTERIAL-PRESSUREAutonomic nervous systemBlood pressuretime series analysisCardiologyinformation decompositionlcsh:QentropyCARDIOPULMONARYlcsh:Physics030217 neurology & neurosurgerycirculatory and respiratory physiologyEntropy (Basel, Switzerland)
researchProduct

Predictors of Progression in Hypertensive Renal Disease in Children

2004

In hypertensive renal disease in children, several risk factors influence the development and the rate of progression of renal damage, including blood pressure levels, proteinuria, lipid disorders, and genetic differences. The impact of blood pressure on renal structures, the most important of the factors, depends not only on blood pressure levels, but also on the persistence of the blood pressure levels over time, mainly during the hours when the patient is resting or sleeping. Abnormal circadian variability is frequently observed in patients with renal damage, and nocturnal blood pressure reduction should be a major therapeutic objective to protect against a decline in renal function. Pro…

medicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismRenal functionDiseaseurologic and male genital diseasesRisk FactorsInternal medicineInternal MedicineHumansMedicineIn patientCircadian rhythmChildReview PaperProteinuriabusiness.industryRenal damageAge FactorsPrognosisNocturnal blood pressureProteinuriaBlood pressureEndocrinologyHypertensionDisease ProgressionCardiologyKidney Diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessThe Journal of Clinical Hypertension
researchProduct

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rab…

1996

Objective: The complement system has been suggested to play a role in reperfusion injury which may result from an enhanced destruction of myocardial tissue or from an impairment of reflow. We investigated the influence of the C5b-9 complement complex on infarct size, reflow and arrhythmogenesis. Methods: Twenty-eight C6-competent rabbits and 18 rabbits with congenital C6 deficiency were subjected to either 30 min or 2 h of coronary artery occlusion followed by reperfusion. C6 deficiency was confirmed by the complement titration test and immunohistology. The triphenyl tetrazolium chloride method was used to delineate infarct size. Reflow into infarcted areas was evaluated histologically afte…

medicine.medical_specialtyTime FactorsPhysiologyMyocardial InfarctionIschemiaInfarctionMyocardial Reperfusion InjuryComplement Membrane Attack ComplexElectrocardiographyReperfusion therapyPhysiology (medical)Internal medicinemedicineAnimalscardiovascular diseasesComplement Activationbusiness.industryArrhythmias Cardiacmedicine.diseaseImmunohistochemistryComplement C6Complement systemRegional Blood FlowCoronary occlusionNo reflow phenomenoncardiovascular systemCardiologyRabbitsCardiology and Cardiovascular MedicineComplement membrane attack complexbusinessReperfusion injuryCardiovascular Research
researchProduct

Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Stud…

2013

Primary aldosteronism (PA) is the most common endocrine form of hypertension and may carry an increased risk of atrial flutter or fibrillation (AFF). The primary goal of this multicentre cohort study is thus to prospectively establish the prevalence of PA in consecutive hypertensive patients referred for lone (non-valvular), paroxysmal or permanent AFF. Secondary objectives are to determine: (1) the predictors of AFF in patients with PA; (2) the rate of AFF recurrence at follow-up after specific treatment in the patients with PA; (3) the effect of AFF that can increase atrial natriuretic peptide via the atrial stretch and thereby blunt aldosterone secretion, on the aldosterone-to-renin rati…

medicine.medical_specialtyTime FactorsTime FactorElectric CountershockPlasma renin activityaldosteronism; atrial fibrillation; high blood pressure; plasma reninPrimary aldosteronismRecurrenceInternal medicineatraial fibrillationReninHyperaldosteronismInternal MedicinePrevalenceMedicineHumansSinus rhythmatrial fibrillationprimary aldosteronism; hypertension; atraial fibrillationProspective StudiesProspective cohort studyAldosteroneFibrillationaldosteronismprimary aldosteronismChi-Square Distributionbusiness.industryAtrial fibrillationmedicine.diseaseHyperaldosteronismplasma reninEuropeProspective StudieTreatment OutcomeAtrial FlutterResearch DesignAnti-Arrhythmia AgentBiological MarkerHypertensionCardiologyQuality of Lifemedicine.symptombusinessAnti-Arrhythmia AgentsAtrial flutterBiomarkersHumanhigh blood pressure
researchProduct

Effect of Atrial Capture Beats on the Subsequent Cycle During Slow Common Atrioventricular Nodal Reentry Tachycardia

2013

medicine.medical_specialtyTime Factorsmedicine.diagnostic_testbusiness.industryCardiac anatomyAtrial arrhythmiasMiddle AgedNodal diseasePredictive Value of TestsPhysiology (medical)Predictive value of testsInternal medicineAtrial captureElectrocardiography AmbulatoryTachycardia SupraventricularmedicineCardiologyHumansTachycardia Atrioventricular Nodal ReentryTachycardia ParoxysmalCardiology and Cardiovascular MedicinebusinessElectrocardiographyJournal of Cardiovascular Electrophysiology
researchProduct

Antivitamin K Drugs in Stroke Prevention

2014

Among the different subtypes of ischaemic strokes, almost 20 % are of cardiac origin. Different are the causes of cardioembolic stroke, but the most common is the atrial fibrillation, a supraventricular arrhythmia. Appropriate use of antiplatelet drugs and anticoagulants after transient ischaemic attack (TIA) or ischaemic stroke depends on whether the underlying cause is cardioembolic or of presumed arterial origin. Adequate antiplatelet therapy is recommended for secondary prevention after cerebral ischaemia of presumed arterial origin, whether for patients with TIA and ischaemic stroke of cardiac origin, mainly due to atrial fibrillation. Vitamin K antagonists (VKAs) are highly effective …

medicine.medical_specialtyVitamin KSettore MED/09 - Medicina InternaAppropriate useInternal medicinemedicineAnimalsHumanscardiovascular diseasesRandomized Controlled Trials as TopicPharmacologySupraventricular arrhythmiabusiness.industryPatient choiceStandard treatmentAnticoagulantsVKAs Stroke preventionAtrial fibrillationmedicine.diseaseStrokeIschemic Attack TransientStroke preventionCardiologyCerebral ischaemiaCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsDiscovery and development of direct thrombin inhibitorsCurrent Vascular Pharmacology
researchProduct